German Water Utilities Stock News

XTRA:ADS
XTRA:ADSLuxury

A Look At adidas (XTRA:ADS) Valuation After Announcing A €1,000 Million Share Buyback Program

What adidas’ new €1,000 million buyback could mean for shareholders adidas (XTRA:ADS) has kicked off 2026 with a fresh share repurchase plan, authorizing up to €1,000 million of buybacks through 2026, with the repurchased shares set to be cancelled. See our latest analysis for adidas. At a share price of €153.6, adidas has seen a 7.83% 1 month share price decline and an 8.24% year to date share price decline, while the 1 year total shareholder return of 39.75% decline contrasts with an 11.55%...
XTRA:ALV
XTRA:ALVInsurance

Assessing Allianz (XTRA:ALV) Valuation As Long Term Returns And Cash Flow Signals Converge

How Allianz is currently positioned With no single fresh headline driving Allianz (XTRA:ALV) today, the stock’s current position reflects its recent performance, income profile, and the scale of its global insurance and asset management operations. See our latest analysis for Allianz. At a share price of €387.4, Allianz has posted a 7.91% 90 day share price return, while its 1 year total shareholder return of 26.28% and 5 year total shareholder return of 148.24% point to momentum that has...
XTRA:AMV0
XTRA:AMV0Auto Components

Aumovio (XTRA:AMV0) Valuation Check After Mixed Short Term Share Price Performance

Aumovio (XTRA:AMV0) is drawing attention after recent trading left the shares at €41.96, with returns mixed over the past week, month, and past 3 months as investors reassess this newly listed mobility specialist. See our latest analysis for Aumovio. That recent 1 day share price return of 1.80% comes after a 30 day share price return of an 8.10% decline and a year to date share price return of a 5.88% decline, suggesting short term momentum is picking up after a softer start. If this price...
XTRA:AIXA
XTRA:AIXASemiconductor

AIXTRON (XTRA:AIXA) Is Up 7.7% After AI-Focused GaN and SiC Tool Orders Surge – What's Changed

Aixtron SE recently reported a surge in orders for its equipment used in AI-related semiconductors, particularly for GaN and SiC production lines, alongside increasing demand from optical and laser component markets. This momentum highlights how AI-driven capital expenditure is broadening Aixtron’s end-market exposure across power electronics, photonics, and advanced manufacturing ecosystems. We’ll now look at how rising AI-related equipment demand, especially in GaN and SiC tools, may...
XTRA:SFQ
XTRA:SFQAuto Components

3 European Dividend Stocks Offering Up To 5.5% Yield

As optimism about the eurozone economy bolsters investor sentiment, European markets have shown resilience amid recent volatility, with major indexes like Germany's DAX and France's CAC 40 posting gains. In this environment, dividend stocks can offer a compelling option for investors seeking steady income streams; these stocks are often valued for their ability to provide returns even when market conditions fluctuate.
XTRA:BMW
XTRA:BMWAuto

A Look At BMW (XTRA:BMW) Valuation After Recent Share Price Softness

Bayerische Motoren Werke stock snapshot after recent performance shifts Bayerische Motoren Werke (XTRA:BMW) has drawn attention after a recent mix of short term return moves, including a 0.2% decline over the past day and a 4.1% decline over the past month. See our latest analysis for Bayerische Motoren Werke. While the recent 30 day share price return of 4.11% decline and year to date share price return of 8.39% decline point to fading near term momentum, the 1 year total shareholder return...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Will OCEANIC-STROKE’s Asundexian Data Shift Bayer’s (XTRA:BAYN) Narrative on Innovation and Risk?

In early February 2026, Bayer reported pivotal Phase III OCEANIC-STROKE results showing its investigational Factor XIa inhibitor asundexian reduced recurrent ischemic stroke without increasing major bleeding versus placebo, both on top of antiplatelet therapy. A key insight from OCEANIC-STROKE is that asundexian delivered stroke risk reduction across all enrolled TOAST stroke subtypes, while maintaining a bleeding profile comparable to placebo. Against this backdrop, we’ll examine how the...
XTRA:PUM
XTRA:PUMLuxury

PUMA (XTRA:PUM) Valuation Check After New Dedicated Training Business Unit Announcement

Why PUMA (XTRA:PUM) Is Back in Focus After Its New Training Unit PUMA (XTRA:PUM) is creating a dedicated Business Unit for Training at its Herzogenaurach headquarters, separating it from Running to sharpen category focus and simplify decisions across its wider apparel portfolio. See our latest analysis for PUMA. The Training unit announcement comes as PUMA’s share price sits at €23.15, with a strong 90 day share price return of 37.63% contrasting with a weaker 1 year total shareholder return...
XTRA:MBG
XTRA:MBGAuto

Assessing Mercedes-Benz Group (XTRA:MBG) Valuation After Recent Share Price Softness

Why Mercedes-Benz Group (XTRA:MBG) is on investors’ radar today Mercedes-Benz Group (XTRA:MBG) has drawn attention after recent share price softness, with the stock down about 3% over the past month and 6% year to date based on the latest close. See our latest analysis for Mercedes-Benz Group. At the latest share price of €58.31, Mercedes-Benz Group’s short term share price return has been slightly negative in recent weeks, while its 1 year total shareholder return of 10.1% and 5 year total...
XTRA:BAS
XTRA:BASChemicals

Is BASF (XTRA:BAS) Pricing Look Attractive After Recent Share Price Gains?

If you are wondering whether BASF at around €48.77 is offering good value today, you are not alone. This article will help you frame that question clearly. The share price has recently moved, with returns of 4.6% over 7 days, 8.5% over 30 days, 8.9% year to date, 8.6% over 1 year and 14.7% over 3 years, while the 5 year return sits at a 1.1% decline. Recent attention around BASF has focused on its position as a major European chemicals group and how it fits into broader discussions about...
XTRA:DHER
XTRA:DHERHospitality

Assessing Delivery Hero (XTRA:DHER) Valuation After Cost Cuts And Exit From Underperforming Regions

Delivery Hero (XTRA:DHER) is back in focus after management launched a broad strategy review, streamlined costs, and exited underperforming regions. These moves are reshaping how investors look at the food delivery group. See our latest analysis for Delivery Hero. The recent strategy review and cost focus comes after a sharp 7 day share price return of negative 13.89% and a 1 year total shareholder return of negative 16.96%, despite a 90 day share price return of 26.67%. This suggests that...
XTRA:TMV
XTRA:TMVSoftware

TeamViewer (XTRA:TMV) Valuation Check After New Thrive Collaboration On Proactive IT Services

TeamViewer (XTRA:TMV) has entered a new partnership with Thrive, integrating its Digital Employee Experience capabilities into Thrive's ServiceNow based NextGen managed services platform to support more proactive IT operations and automation. See our latest analysis for TeamViewer. At a share price of €5.705, TeamViewer has seen pressure build over time, with a 30 day share price return of 4.76% and a 1 year total shareholder return decline of 50.54%. Recent partnership news may be watched...
XTRA:NDA
XTRA:NDAMetals and Mining

Aurubis (XTRA:NDA) Valuation Check After Upgraded 2025–26 Earnings Guidance And Stronger Copper Trends

Why Aurubis stock is back on investors’ radar Aurubis (XTRA:NDA) has drawn fresh attention after raising its 2025–26 operating EBT guidance to €375 million to €475 million. This follows a first quarter with higher sales and net income versus a year earlier. See our latest analysis for Aurubis. The raised guidance and strong first quarter have coincided with a sharp move in the stock, with a 30.35% year to date share price return and a 102.07% total shareholder return over the past year...
XTRA:EVK
XTRA:EVKChemicals

Evaluating Evonik Industries (XTRA:EVK) Valuation After Annual Results And Dividend Confirmation

What the latest earnings and dividend mean for Evonik Industries (XTRA:EVK) Evonik Industries (XTRA:EVK) reported full year 2025 results with sales of €14,069 million and net income of €634 million, alongside confirming an annual dividend of €1.00 per share payable in June 2026. See our latest analysis for Evonik Industries. The release of full year 2025 results, which showed sales of €14.1b and net income of €634 million, appears to be in focus for investors. The 7 day share price return of...